ACR 2022 Tweet by David Liew

Are preexisting autoimmune dx pts okay for
PD-1i/CTLA-4i combo immunoRx
(vs PD-1i single agent)?

Common question in practice for your rheum pts who get cancer

Combo ICI means:
de novo irAE: double risk
flares: same risk

Give our pts what they need!

ABST0757 #ACR22 @RheumNow